282 related articles for article (PubMed ID: 17255143)
1. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
4. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis.
Wang H; Huang T; Jing J; Jin J; Wang P; Yang M; Cui W; Zheng Y; Shen H
J Hosp Infect; 2010 Sep; 76(1):1-11. PubMed ID: 20638155
[TBL] [Abstract][Full Text] [Related]
6. New choices for central venous catheters: potential financial implications.
Shorr AF; Humphreys CW; Helman DL
Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
[TBL] [Abstract][Full Text] [Related]
7. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
8. Central venous catheterization: a prospective, randomized, double-blind study.
Mer M; Duse AG; Galpin JS; Richards GA
Clin Appl Thromb Hemost; 2009 Feb; 15(1):19-26. PubMed ID: 18593746
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis.
Casey AL; Mermel LA; Nightingale P; Elliott TS
Lancet Infect Dis; 2008 Dec; 8(12):763-76. PubMed ID: 19022192
[TBL] [Abstract][Full Text] [Related]
10. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?
McConnell SA; Gubbins PO; Anaissie EJ
Clin Infect Dis; 2003 Jul; 37(1):65-72. PubMed ID: 12830410
[TBL] [Abstract][Full Text] [Related]
11. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
Schumm K; Lam TB
Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
14. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
[TBL] [Abstract][Full Text] [Related]
15. Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash.
McConnell SA; Gubbins PO; Anaissie EJ
Clin Infect Dis; 2004 Dec; 39(12):1829-33. PubMed ID: 15578407
[TBL] [Abstract][Full Text] [Related]
16. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters.
Aslam S; Darouiche RO
J Antimicrob Chemother; 2007 Jul; 60(1):148-51. PubMed ID: 17525051
[TBL] [Abstract][Full Text] [Related]
17. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis.
Ho KM; Litton E
J Antimicrob Chemother; 2006 Aug; 58(2):281-7. PubMed ID: 16757502
[TBL] [Abstract][Full Text] [Related]
18. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
[TBL] [Abstract][Full Text] [Related]
19. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia.
Moretti EW; Ofstead CL; Kristy RM; Wetzler HP
J Hosp Infect; 2005 Oct; 61(2):139-45. PubMed ID: 16026898
[TBL] [Abstract][Full Text] [Related]
20. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
